Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02614833
Brief Title: IMP321 (Eftilagimod Alpha) as Adjunctive to a Standard Chemotherapy Paclitaxel Metastatic Breast Carcinoma

First Submitted : November 5, 2015
First Submitted that Met QC Criteria : November 22, 2015
First Posted : November 25, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : November 10, 2020
Last Update Posted : November 12, 2020